 | • レポートコード：QFJ1-3951 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、悪液質治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（減量安定剤、食欲促進剤、プロゲストゲン、コルチコステロイド、併用療法、その他）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・悪液質治療の市場動向 ・企業の競争状況、市場シェア ・悪液質治療の種類別市場規模と予測2016-2027（減量安定剤、食欲促進剤、プロゲストゲン、コルチコステロイド、併用療法、その他） ・悪液質治療の用途別市場規模と予測2016-2027（病院薬局、小売薬局、ドラッグストア、オンライン） ・悪液質治療の北米市場規模2016-2027（アメリカ、カナダ） ・悪液質治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・悪液質治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・悪液質治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・悪液質治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Alder Biopharmaceuticals Inc.、GTx Inc.、Helsinn Group、Merck & Co. Inc.、Bristol-Myers Squibb Company、Helsinn Healthcare S.A.、PsiOxus、Purdue Pharma L.P.、Eterna Zentaris Inc.、Aphios Corporation、Neurim、Novartis AG、SkyePharma） ・結論 |
Cachexia is a wasting syndrome characterized by extreme weight loss, anorexia, asthenia and anaemia. This syndrome affects populations who were in the late stages of severe diseases like cancer, HIV or AIDS, kidney disease, COPD and congestive heart failure (CHF). Appetite stimulants, anti-inflammatory drugs, Corticosteroids, Enobosarm and Other Anabolics are most commonly used for cachexia treatment.
Market Analysis and Insights: Global Cachexia Treatment Market
The global Cachexia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cachexia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cachexia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cachexia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cachexia Treatment market.
Global Cachexia Treatment Scope and Market Size
Cachexia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cachexia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Weight Loss Stabilizers
Appetite Stimulants
Progestogens
Corticosteroids
Combination therapies
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Alder Biopharmaceuticals Inc.
GTx Inc.
Helsinn Group
Merck & Co. Inc.
Bristol-Myers Squibb Company
Helsinn Healthcare S.A.
PsiOxus
Purdue Pharma L.P.
Eterna Zentaris Inc.
Aphios Corporation
Neurim
Novartis AG
SkyePharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cachexia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Weight Loss Stabilizers
1.2.3 Appetite Stimulants
1.2.4 Progestogens
1.2.5 Corticosteroids
1.2.6 Combination therapies
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cachexia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cachexia Treatment Market Perspective (2016-2027)
2.2 Cachexia Treatment Growth Trends by Regions
2.2.1 Cachexia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cachexia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Cachexia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Cachexia Treatment Industry Dynamic
2.3.1 Cachexia Treatment Market Trends
2.3.2 Cachexia Treatment Market Drivers
2.3.3 Cachexia Treatment Market Challenges
2.3.4 Cachexia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cachexia Treatment Players by Revenue
3.1.1 Global Top Cachexia Treatment Players by Revenue (2016-2021)
3.1.2 Global Cachexia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Cachexia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cachexia Treatment Revenue
3.4 Global Cachexia Treatment Market Concentration Ratio
3.4.1 Global Cachexia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cachexia Treatment Revenue in 2020
3.5 Cachexia Treatment Key Players Head office and Area Served
3.6 Key Players Cachexia Treatment Product Solution and Service
3.7 Date of Enter into Cachexia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cachexia Treatment Breakdown Data by Type
4.1 Global Cachexia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Cachexia Treatment Forecasted Market Size by Type (2022-2027)
5 Cachexia Treatment Breakdown Data by Application
5.1 Global Cachexia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Cachexia Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cachexia Treatment Market Size (2016-2027)
6.2 North America Cachexia Treatment Market Size by Type
6.2.1 North America Cachexia Treatment Market Size by Type (2016-2021)
6.2.2 North America Cachexia Treatment Market Size by Type (2022-2027)
6.2.3 North America Cachexia Treatment Market Size by Type (2016-2027)
6.3 North America Cachexia Treatment Market Size by Application
6.3.1 North America Cachexia Treatment Market Size by Application (2016-2021)
6.3.2 North America Cachexia Treatment Market Size by Application (2022-2027)
6.3.3 North America Cachexia Treatment Market Size by Application (2016-2027)
6.4 North America Cachexia Treatment Market Size by Country
6.4.1 North America Cachexia Treatment Market Size by Country (2016-2021)
6.4.2 North America Cachexia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cachexia Treatment Market Size (2016-2027)
7.2 Europe Cachexia Treatment Market Size by Type
7.2.1 Europe Cachexia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Cachexia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Cachexia Treatment Market Size by Type (2016-2027)
7.3 Europe Cachexia Treatment Market Size by Application
7.3.1 Europe Cachexia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Cachexia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Cachexia Treatment Market Size by Application (2016-2027)
7.4 Europe Cachexia Treatment Market Size by Country
7.4.1 Europe Cachexia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Cachexia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cachexia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Cachexia Treatment Market Size by Type
8.2.1 Asia-Pacific Cachexia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cachexia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cachexia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Cachexia Treatment Market Size by Application
8.3.1 Asia-Pacific Cachexia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cachexia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cachexia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Cachexia Treatment Market Size by Region
8.4.1 Asia-Pacific Cachexia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cachexia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cachexia Treatment Market Size (2016-2027)
9.2 Latin America Cachexia Treatment Market Size by Type
9.2.1 Latin America Cachexia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Cachexia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Cachexia Treatment Market Size by Type (2016-2027)
9.3 Latin America Cachexia Treatment Market Size by Application
9.3.1 Latin America Cachexia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Cachexia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Cachexia Treatment Market Size by Application (2016-2027)
9.4 Latin America Cachexia Treatment Market Size by Country
9.4.1 Latin America Cachexia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Cachexia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cachexia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Cachexia Treatment Market Size by Type
10.2.1 Middle East & Africa Cachexia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cachexia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cachexia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Cachexia Treatment Market Size by Application
10.3.1 Middle East & Africa Cachexia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cachexia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cachexia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Cachexia Treatment Market Size by Country
10.4.1 Middle East & Africa Cachexia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cachexia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alder Biopharmaceuticals Inc.
11.1.1 Alder Biopharmaceuticals Inc. Company Details
11.1.2 Alder Biopharmaceuticals Inc. Business Overview
11.1.3 Alder Biopharmaceuticals Inc. Cachexia Treatment Introduction
11.1.4 Alder Biopharmaceuticals Inc. Revenue in Cachexia Treatment Business (2016-2021)
11.1.5 Alder Biopharmaceuticals Inc. Recent Development
11.2 GTx Inc.
11.2.1 GTx Inc. Company Details
11.2.2 GTx Inc. Business Overview
11.2.3 GTx Inc. Cachexia Treatment Introduction
11.2.4 GTx Inc. Revenue in Cachexia Treatment Business (2016-2021)
11.2.5 GTx Inc. Recent Development
11.3 Helsinn Group
11.3.1 Helsinn Group Company Details
11.3.2 Helsinn Group Business Overview
11.3.3 Helsinn Group Cachexia Treatment Introduction
11.3.4 Helsinn Group Revenue in Cachexia Treatment Business (2016-2021)
11.3.5 Helsinn Group Recent Development
11.4 Merck & Co. Inc.
11.4.1 Merck & Co. Inc. Company Details
11.4.2 Merck & Co. Inc. Business Overview
11.4.3 Merck & Co. Inc. Cachexia Treatment Introduction
11.4.4 Merck & Co. Inc. Revenue in Cachexia Treatment Business (2016-2021)
11.4.5 Merck & Co. Inc. Recent Development
11.5 Bristol-Myers Squibb Company
11.5.1 Bristol-Myers Squibb Company Company Details
11.5.2 Bristol-Myers Squibb Company Business Overview
11.5.3 Bristol-Myers Squibb Company Cachexia Treatment Introduction
11.5.4 Bristol-Myers Squibb Company Revenue in Cachexia Treatment Business (2016-2021)
11.5.5 Bristol-Myers Squibb Company Recent Development
11.6 Helsinn Healthcare S.A.
11.6.1 Helsinn Healthcare S.A. Company Details
11.6.2 Helsinn Healthcare S.A. Business Overview
11.6.3 Helsinn Healthcare S.A. Cachexia Treatment Introduction
11.6.4 Helsinn Healthcare S.A. Revenue in Cachexia Treatment Business (2016-2021)
11.6.5 Helsinn Healthcare S.A. Recent Development
11.7 PsiOxus
11.7.1 PsiOxus Company Details
11.7.2 PsiOxus Business Overview
11.7.3 PsiOxus Cachexia Treatment Introduction
11.7.4 PsiOxus Revenue in Cachexia Treatment Business (2016-2021)
11.7.5 PsiOxus Recent Development
11.8 Purdue Pharma L.P.
11.8.1 Purdue Pharma L.P. Company Details
11.8.2 Purdue Pharma L.P. Business Overview
11.8.3 Purdue Pharma L.P. Cachexia Treatment Introduction
11.8.4 Purdue Pharma L.P. Revenue in Cachexia Treatment Business (2016-2021)
11.8.5 Purdue Pharma L.P. Recent Development
11.9 Eterna Zentaris Inc.
11.9.1 Eterna Zentaris Inc. Company Details
11.9.2 Eterna Zentaris Inc. Business Overview
11.9.3 Eterna Zentaris Inc. Cachexia Treatment Introduction
11.9.4 Eterna Zentaris Inc. Revenue in Cachexia Treatment Business (2016-2021)
11.9.5 Eterna Zentaris Inc. Recent Development
11.10 Aphios Corporation
11.10.1 Aphios Corporation Company Details
11.10.2 Aphios Corporation Business Overview
11.10.3 Aphios Corporation Cachexia Treatment Introduction
11.10.4 Aphios Corporation Revenue in Cachexia Treatment Business (2016-2021)
11.10.5 Aphios Corporation Recent Development
11.11 Neurim
11.11.1 Neurim Company Details
11.11.2 Neurim Business Overview
11.11.3 Neurim Cachexia Treatment Introduction
11.11.4 Neurim Revenue in Cachexia Treatment Business (2016-2021)
11.11.5 Neurim Recent Development
11.12 Novartis AG
11.12.1 Novartis AG Company Details
11.12.2 Novartis AG Business Overview
11.12.3 Novartis AG Cachexia Treatment Introduction
11.12.4 Novartis AG Revenue in Cachexia Treatment Business (2016-2021)
11.12.5 Novartis AG Recent Development
11.13 SkyePharma
11.13.1 SkyePharma Company Details
11.13.2 SkyePharma Business Overview
11.13.3 SkyePharma Cachexia Treatment Introduction
11.13.4 SkyePharma Revenue in Cachexia Treatment Business (2016-2021)
11.13.5 SkyePharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cachexia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Weight Loss Stabilizers
Table 3. Key Players of Appetite Stimulants
Table 4. Key Players of Progestogens
Table 5. Key Players of Corticosteroids
Table 6. Key Players of Combination therapies
Table 7. Key Players of Others
Table 8. Global Cachexia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cachexia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Cachexia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Cachexia Treatment Market Share by Regions (2016-2021)
Table 12. Global Cachexia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Cachexia Treatment Market Share by Regions (2022-2027)
Table 14. Cachexia Treatment Market Trends
Table 15. Cachexia Treatment Market Drivers
Table 16. Cachexia Treatment Market Challenges
Table 17. Cachexia Treatment Market Restraints
Table 18. Global Cachexia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Cachexia Treatment Market Share by Players (2016-2021)
Table 20. Global Top Cachexia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cachexia Treatment as of 2020)
Table 21. Ranking of Global Top Cachexia Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Cachexia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cachexia Treatment Product Solution and Service
Table 25. Date of Enter into Cachexia Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cachexia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Cachexia Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Cachexia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Cachexia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Cachexia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Cachexia Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Cachexia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Cachexia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Cachexia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Cachexia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Cachexia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Cachexia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Cachexia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Cachexia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Cachexia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Cachexia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Cachexia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Cachexia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Cachexia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Cachexia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cachexia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cachexia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cachexia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Cachexia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Cachexia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Cachexia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Cachexia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Cachexia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Cachexia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Cachexia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Cachexia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Cachexia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cachexia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cachexia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cachexia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Cachexia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Cachexia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Cachexia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. Alder Biopharmaceuticals Inc. Company Details
Table 66. Alder Biopharmaceuticals Inc. Business Overview
Table 67. Alder Biopharmaceuticals Inc. Cachexia Treatment Product
Table 68. Alder Biopharmaceuticals Inc. Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 69. Alder Biopharmaceuticals Inc. Recent Development
Table 70. GTx Inc. Company Details
Table 71. GTx Inc. Business Overview
Table 72. GTx Inc. Cachexia Treatment Product
Table 73. GTx Inc. Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 74. GTx Inc. Recent Development
Table 75. Helsinn Group Company Details
Table 76. Helsinn Group Business Overview
Table 77. Helsinn Group Cachexia Treatment Product
Table 78. Helsinn Group Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 79. Helsinn Group Recent Development
Table 80. Merck & Co. Inc. Company Details
Table 81. Merck & Co. Inc. Business Overview
Table 82. Merck & Co. Inc. Cachexia Treatment Product
Table 83. Merck & Co. Inc. Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 84. Merck & Co. Inc. Recent Development
Table 85. Bristol-Myers Squibb Company Company Details
Table 86. Bristol-Myers Squibb Company Business Overview
Table 87. Bristol-Myers Squibb Company Cachexia Treatment Product
Table 88. Bristol-Myers Squibb Company Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 89. Bristol-Myers Squibb Company Recent Development
Table 90. Helsinn Healthcare S.A. Company Details
Table 91. Helsinn Healthcare S.A. Business Overview
Table 92. Helsinn Healthcare S.A. Cachexia Treatment Product
Table 93. Helsinn Healthcare S.A. Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 94. Helsinn Healthcare S.A. Recent Development
Table 95. PsiOxus Company Details
Table 96. PsiOxus Business Overview
Table 97. PsiOxus Cachexia Treatment Product
Table 98. PsiOxus Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 99. PsiOxus Recent Development
Table 100. Purdue Pharma L.P. Company Details
Table 101. Purdue Pharma L.P. Business Overview
Table 102. Purdue Pharma L.P. Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 103. Purdue Pharma L.P. Recent Development
Table 104. Eterna Zentaris Inc. Company Details
Table 105. Eterna Zentaris Inc. Business Overview
Table 106. Eterna Zentaris Inc. Cachexia Treatment Product
Table 107. Eterna Zentaris Inc. Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 108. Eterna Zentaris Inc. Recent Development
Table 109. Aphios Corporation Company Details
Table 110. Aphios Corporation Business Overview
Table 111. Aphios Corporation Cachexia Treatment Product
Table 112. Aphios Corporation Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 113. Aphios Corporation Recent Development
Table 114. Neurim Company Details
Table 115. Neurim Business Overview
Table 116. Neurim Cachexia Treatment Product
Table 117. Neurim Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 118. Neurim Recent Development
Table 119. Novartis AG Company Details
Table 120. Novartis AG Business Overview
Table 121. Novartis AG Cachexia Treatment Product
Table 122. Novartis AG Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 123. Novartis AG Recent Development
Table 124. SkyePharma Company Details
Table 125. SkyePharma Business Overview
Table 126. SkyePharma Cachexia Treatment Product
Table 127. SkyePharma Revenue in Cachexia Treatment Business (2016-2021) & (US$ Million)
Table 128. SkyePharma Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cachexia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Weight Loss Stabilizers Features
Figure 3. Appetite Stimulants Features
Figure 4. Progestogens Features
Figure 5. Corticosteroids Features
Figure 6. Combination therapies Features
Figure 7. Others Features
Figure 8. Global Cachexia Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Drug Stores Case Studies
Figure 12. Online Case Studies
Figure 13. Cachexia Treatment Report Years Considered
Figure 14. Global Cachexia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Cachexia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Cachexia Treatment Market Share by Regions: 2020 VS 2027
Figure 17. Global Cachexia Treatment Market Share by Regions (2022-2027)
Figure 18. Global Cachexia Treatment Market Share by Players in 2020
Figure 19. Global Top Cachexia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cachexia Treatment as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Cachexia Treatment Revenue in 2020
Figure 21. Global Cachexia Treatment Revenue Market Share by Type (2016-2021)
Figure 22. Global Cachexia Treatment Revenue Market Share by Type (2022-2027)
Figure 23. North America Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Cachexia Treatment Market Share by Type (2016-2027)
Figure 25. North America Cachexia Treatment Market Share by Application (2016-2027)
Figure 26. North America Cachexia Treatment Market Share by Country (2016-2027)
Figure 27. United States Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Cachexia Treatment Market Share by Type (2016-2027)
Figure 31. Europe Cachexia Treatment Market Share by Application (2016-2027)
Figure 32. Europe Cachexia Treatment Market Share by Country (2016-2027)
Figure 33. Germany Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Cachexia Treatment Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Cachexia Treatment Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Cachexia Treatment Market Share by Region (2016-2027)
Figure 43. China Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Cachexia Treatment Market Share by Type (2016-2027)
Figure 51. Latin America Cachexia Treatment Market Share by Application (2016-2027)
Figure 52. Latin America Cachexia Treatment Market Share by Country (2016-2027)
Figure 53. Mexico Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Cachexia Treatment Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Cachexia Treatment Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Cachexia Treatment Market Share by Country (2016-2027)
Figure 59. Turkey Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Cachexia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Alder Biopharmaceuticals Inc. Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 63. GTx Inc. Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 64. Helsinn Group Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 65. Merck & Co. Inc. Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 66. Bristol-Myers Squibb Company Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 67. Helsinn Healthcare S.A. Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 68. PsiOxus Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 69. Purdue Pharma L.P. Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 70. Eterna Zentaris Inc. Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 71. Aphios Corporation Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 72. Neurim Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 73. Novartis AG Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 74. SkyePharma Revenue Growth Rate in Cachexia Treatment Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の骨髄性プロトポルフィリン症（EPP）治療市場規模・現状・予測（2021年-2027年） Erythropoietic protoporphyria (EPP) is a rare inherited metabolic disorder caused by a deficiency of the enzyme ferrochelatase (FECH), which results from changes (mutations) in the FECH gene. Due to abnormally low levels of this enzyme, excessive amounts of protoporphyrin accumulate in the bone marr…- 世界の前頭側頭型認知症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Frontotemporal Disorders Treatment Market The global Frontotemporal Disorders Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
- 世界の好中球減少症生物学的製剤治療市場規模・現状・予測（2021年-2027年） Neutropenia is a clinical condition characterized by a decrease in neutrophil count in the blood, resulting in a higher risk of developing serious infections. A neutrophil is a type of white blood cell, which helps in fighting infections. The major causes of neutropenia include cancer chemotherapy,…
- 世界の後腹膜線維症治療市場規模・現状・予測（2021年-2027年） Retroperitoneal fibrosis is the rare disease also known as Ormond’s disease. Retroperitoneal fibrosis is characterized by the inflammatory disorder in which abnormal formation of tissue or fibrosis occurs in the back of the abdominal cavity and behind the retro membrane. This area is known as retrop…
- 世界のアルコール性肝疾患治療市場規模・現状・予測（2021年-2027年） Alcoholic liver diseases are the result of overconsumption of alcohol, which damages the liver, leading to liver cirrhosis, inflammation, and liver scarring. Market Analysis and Insights: Global Alcoholic Liver Diseases Treatment Market The global Alcoholic Liver Diseases Treatment market size is p…